Trials / Completed
CompletedNCT04640207
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
Prospective, Single-Center, Open-Label Study to Evaluate the Efficacy of the Alma Hybrid System for New Approach of Facial Skin Treatment With Minimal Downtime
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Alma Lasers · Industry
- Sex
- All
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Facial skin treatment | Facial skin treatment using the Alma Hybrid system with a unique pattern that includes both ablative and non-ablative wavelengths |
Timeline
- Start date
- 2020-11-25
- Primary completion
- 2021-07-18
- Completion
- 2021-07-18
- First posted
- 2020-11-23
- Last updated
- 2021-07-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04640207. Inclusion in this directory is not an endorsement.